ISSN: 0167-7659

Journal Home

Journal Guideline

Cancer and Metastasis Reviews Q1 Unclaimed

Springer Netherlands Netherlands

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer and Metastasis Reviews is a journal indexed in SJR in Oncology and Cancer Research with an H index of 148. It has a price of 2690 €. It has an SJR impact factor of 2,555 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,555.

Cancer and Metastasis Reviews focuses its scope in these topics and keywords: cancer, tumor, cell, monocyte, molecular, microenvironmentpersonalized, microenvironmentccl, metastasisstructure, metastaseshuman, melanoma, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q1) Oncology (Q1)

Price

2690 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

2,555

SJR Impact factor

148

H Index

87

Total Docs (Last Year)

179

Total Docs (3 years)

10312

Total Refs

1457

Total Cites (3 years)

170

Citable Docs (3 years)

7,7

Cites/Doc (2 years)

118,53

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

JAMA oncology Q1
Annals of Oncology Q1
Molecular Cancer Q1
CA - A Cancer Journal for Clinicians Q1
Cancer Discovery Q1

Compare this journals

Aims and Scope

Best articles by citations

TGF and Wnt pathway cross-talk

Surgical treatment of colorectal cancer metastasis

Current and future trends in colorectal cancer screening

Cathepsin B and its endogenous inhibitors: the role in tumor malignancy

Anesthetic technique and cancer recurrence in oncologic surgery: unraveling the puzzle

Bone morphogenetic proteins in melanoma: Angel or devil?

Treatment of colorectal cancer metastasis: The role of chemotherapy

Implications of intermediate filament protein phosphorylation